Where does Cell Cure Neurosciences Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cell Cure Neurosciences Ltd. ranks #31,150 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cell Cure Neurosciences Ltd. hold?

Cell Cure Neurosciences Ltd. holds 8 US utility patents granted between 2017 and 2025, spanning 5 technology areas.

What is Cell Cure Neurosciences Ltd.'s Innovation Score?

Cell Cure Neurosciences Ltd. has an Innovation Score of 32.2 out of 100 (40th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cell Cure Neurosciences Ltd.'s patent grant rate increasing or decreasing?

Cell Cure Neurosciences Ltd.'s recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Cell Cure Neurosciences Ltd.'s patents?

Cell Cure Neurosciences Ltd.'s patents average 20.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cell Cure Neurosciences Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cell Cure Neurosciences Ltd.

Q: What technology areas does Cell Cure Neurosciences Ltd. focus on?

Cell Cure Neurosciences Ltd.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 8 patents, ranking #1,253 of 4,144 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 5 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cell ranks #31,150 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 5 technology areas.

#31,150
of 49,997 US assignees by volume: 40th percentile
by Innovation Score (32.2/100): 20.4
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R31150 · Foreign Corporation #31,150 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #31,150/49,997
PHOTO-FINISH Catcher Technology
CPC-NARROW C12N · 5 areas
INNOV-THIN 32.2/100
CLAIMS-DENSE 20.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Catcher Technology Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cell’s 32.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (24%) Velocity 4.4 pts (14%) Breadth 7.9 pts (25%) Claim depth 12.2 pts (38%)

Qualcomm Incorporated · highest

85
Cell Cure Neuroscien… · this assignee

32
3D Lighting… · lowest

7

What this shows Cell's Innovation Score is 32.2/100 (40th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cell?

Each dot is one of Cell’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cell’s own 20.4 claims/patent is ABOVE the 10.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cell vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cell's grants concentrate

Cell Cure Neurosciences Ltd. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2017. By volume, Cell sits between Catcher Technology Co., Ltd. and Celluforce.

Cell's three-year grant acceleration

Cell Cure Neurosciences Ltd. shows 2 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Catcher Technology

8
Cbrn International

8
Ccys Hi-tech Inte…

8
Cebi Electromecha…

8
Cell Therapy Hold…

8
Cellectar Bioscie…

8
Cellscript

8
Celluforce

8
Cell Cure Neurosc… ◀

8

What this shows Cell holds 8 patents at rank #31,134, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cell

By rank, the assignees closest to #31,134 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Cell's primary technology class.

Cell's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 40th percentile higher than 40% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Cell Cure Neurosciences Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	12.5%
2021	3	37.5%
2024	2	25.0%
2025partial year	2	25.0%

Which technologies does Cell Cure Neurosciences Ltd. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cell Cure Neurosciences Ltd.'s patent record in context - here's where to go next.

Cell Cure Neurosciences Ltd.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #31,150 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cell Cure Neurosciences Ltd. against Catcher Technology Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.